Chêne L - Search Results

1

Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene.

Chêne L, Giroud C, Desgrandchamps F, Boccon-Gibod L, Cussenot O, Berthon P, Latil A. Chêne L, et al. Int J Cancer. 2004 Sep 20;111(5):798-804. doi: 10.1002/ijc.20337. Int J Cancer. 2004. PMID: 15252854 Free article.

2

Quantification of expression of netrins, slits and their receptors in human prostate tumors.

Latil A, Chêne L, Cochant-Priollet B, Mangin P, Fournier G, Berthon P, Cussenot O. Latil A, et al. Among authors: chene l. Int J Cancer. 2003 Jan 20;103(3):306-15. doi: 10.1002/ijc.10821. Int J Cancer. 2003. PMID: 12471613 Free article.

3

Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.

Latil A, Chêne L, Mangin P, Fournier G, Berthon P, Cussenot O. Latil A, et al. Among authors: chene l. Prostate. 2003 Sep 15;57(1):39-50. doi: 10.1002/pros.10272. Prostate. 2003. PMID: 12886522

4

Gene expression profiling in clinically localized prostate cancer: a four-gene expression model predicts clinical behavior.

Latil A, Bièche I, Chêne L, Laurendeau I, Berthon P, Cussenot O, Vidaud M. Latil A, et al. Among authors: chene l. Clin Cancer Res. 2003 Nov 15;9(15):5477-85. Clin Cancer Res. 2003. PMID: 14654526

5

Differential expression of 37 selected genes in hormone-refractory prostate cancer using quantitative taqman real-time RT-PCR.

Fromont G, Chene L, Vidaud M, Vallancien G, Mangin P, Fournier G, Validire P, Latil A, Cussenot O. Fromont G, et al. Among authors: chene l. Int J Cancer. 2005 Mar 20;114(2):174-81. doi: 10.1002/ijc.20704. Int J Cancer. 2005. PMID: 15543616 Free article.

6

Molecular profiling of benign prostatic hyperplasia using a large scale real-time reverse transcriptase-polymerase chain reaction approach.

Fromont G, Chene L, Latil A, Bieche I, Vidaud M, Vallancien G, Mangin P, Fournier G, Validire P, Cussenot O. Fromont G, et al. Among authors: chene l. J Urol. 2004 Oct;172(4 Pt 1):1382-5. doi: 10.1097/01.ju.0000137819.92305.46. J Urol. 2004. PMID: 15371850

7

New spiro-piperidines as 5-HT2B receptor antagonists.

Bienaymé H, Chêne L, Grisoni S, Grondin A, Kaloun el-B, Poigny S, Rahali H, Tam E. Bienaymé H, et al. Among authors: chene l. Bioorg Med Chem Lett. 2006 Sep 15;16(18):4830-3. doi: 10.1016/j.bmcl.2006.06.068. Epub 2006 Jul 17. Bioorg Med Chem Lett. 2006. PMID: 16844377

8

Interleukin-7 and infection itself by human immunodeficiency virus 1 favor virus persistence in mature CD4(+)CD8(-)CD3(+) thymocytes through sustained induction of Bcl-2.

Guillemard E, Nugeyre MT, Chêne L, Schmitt N, Jacquemot C, Barré-Sinoussi F, Israël N. Guillemard E, et al. Among authors: chene l. Blood. 2001 Oct 1;98(7):2166-74. doi: 10.1182/blood.v98.7.2166. Blood. 2001. PMID: 11568004 Free article.

9

Positive regulation of CXCR4 expression and signaling by interleukin-7 in CD4+ mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virus replication.

Schmitt N, Chêne L, Boutolleau D, Nugeyre MT, Guillemard E, Versmisse P, Jacquemot C, Barré-Sinoussi F, Israël N. Schmitt N, et al. Among authors: chene l. J Virol. 2003 May;77(10):5784-93. doi: 10.1128/jvi.77.10.5784-5793.2003. J Virol. 2003. PMID: 12719571 Free PMC article.

10

A primary malarial infection is composed of a very wide range of genetically diverse but related parasites.

Druilhe P, Daubersies P, Patarapotikul J, Gentil C, Chene L, Chongsuphajaisiddhi T, Mellouk S, Langsley G. Druilhe P, et al. Among authors: chene l. J Clin Invest. 1998 May 1;101(9):2008-16. doi: 10.1172/JCI119890. J Clin Invest. 1998. PMID: 9576766 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page